Skip to main content
. 2019 Nov 13;8(11):1954. doi: 10.3390/jcm8111954

Figure 1.

Figure 1

Figure 1

Figure 1

Positive NFκB staining is associated with lower rates of local progression-free survival (LPFS), distant metastasis-free survival (DMFS), and overall survival (OS) in patients treated with trimodality bladder-preserving therapy, negative p16 staining was a poorer prognosticator of LPFS. Kaplan–Meier curves of (A) LPFS, (B) DMFS, and (C) OS stratified by the immunohistochemical staining of NFκB. (D) Kaplan–Meier curve of LPFS stratified by the immunohistochemical staining of p16.